Clinical Trials Update: Nov. 14, 2008
Crohn's Disease Lung Cancer Melanoma
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
If you are aged 18 to 75, have been diagnosed with Crohn's disease, have active disease confirmed, and are on a stable dose of related medication, you may qualify for this study.
The research site is in West Bloomfield, Mich.
If you are at least 18, have inoperable stage III non-small cell lung cancer, and are stable after primary chemo-radiotherapy within four weeks of entry to this trial, you may be eligible for this study.
The research site is in West Brooksville, Fla.
If you are at least 18, have histologically confirmed metastatic (Stage IV) melanoma of cutaneous origin, an ECOG performance status of 2 or less, and a life expectancy of greater than 12 weeks, you may qualify for this study.
The research site is in Marshfield, Wisc.
Copyright 2008 CenterWatch. All rights reserved.